Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Recursion Pharmaceuticals Inc Cl A (RXRX)

Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Recursion Pharmaceuticals Inc Cl A 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 USA

www.recursion.com P: 385-269-0203 F: 801-821-2872

Description:

Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering. Recursion Pharmaceuticals Inc. is based in SALT LAKE CITY.

Key Statistics

Overview:

Market Capitalization, $K 1,783,363
Enterprise Value, $K 1,389,663
Shares Outstanding, K 234,653
Annual Sales, $ 44,580 K
Annual Net Income, $ -328,070 K
Last Quarter Sales, $ 10,890 K
Last Quarter Net Income, $ -93,000 K
EBIT, $ -350,070 K
EBITDA, $ -325,670 K
60-Month Beta 0.76
% of Insider Shareholders 19.96%
% of Institutional Shareholders 89.06%
Float, K 187,816
% Float 80.04%
Short Volume Ratio 0.30

Growth:

1-Year Return 34.62%
3-Year Return -77.25%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.40 on 02/27/24
Latest Earnings Date 05/13/24
Earnings Per Share ttm -1.55
EPS Growth vs. Prev Qtr 6.98%
EPS Growth vs. Prev Year -29.03%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RXRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -72.88%
Return-on-Assets % -50.89%
Profit Margin % -735.91%
Debt/Equity 0.00
Price/Sales 38.69
Price/Cash Flow N/A
Price/Book 3.74
Book Value/Share 1.98
Interest Coverage -2.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar